跳至主要內容

藥品參考

Bosutinib

Bosutinib is a medicine in the class oncology. It is used for leukemia.

最後更新 來源: US FDA label, EMA SmPC

僅供醫療專業人員參考。本頁為簡要摘要,並非醫療建議,亦不能取代官方仿單或臨床判斷。開立處方或調劑前請務必核實。

本頁的臨床內容僅提供英文版。

重點資訊

藥物類別
Oncology
ATC 代碼
L01EA04
常見劑型
錠劑, 膠囊
常見規格
100 mg
已知交互作用
110 (嚴重: 32 · 中度: 55 · 輕微: 23)
商品名
3
國家與市場
3

劑型、規格與商品名稱會因國家而異。請核對您手上的產品。

用途

作用方式

Bosutinib is a tyrosine kinase inhibitor that inhibits BCR-ABL kinase, which promotes CML, and also inhibits Src-family kinases including Src, Lyn, and Hck.

成人常用劑量(仿單摘要)

Newly-diagnosed chronic phase Ph+ CML: 400 mg orally once daily with food

僅摘錄仿單中第一行劑量說明;完整的劑量內容請見 App。

懷孕與哺乳

懷孕
Unsafe Can cause fetal harm; animal studies showed malformations and fetal death. No human data. Use highly effective contraception during treatment and for 2 weeks after the last dose.
哺乳
Unsafe No human milk data; it passes into rat milk. Breastfeeding is not recommended during treatment and for 2 weeks after the last dose.

已通報的副作用

  • Diarrhea
  • Rash
  • Nausea
  • Abdominal pain
  • Vomiting
  • Fatigue

禁忌症

  • History of hypersensitivity to bosutinib, including anaphylaxis.

哪些人需要特別留意

  • Gastrointestinal toxicity: diarrhea, nausea, vomiting, abdominal pain; manage with antidiarrheals, antiemetics, fluids.
  • Myelosuppression: CBC weekly for the first month, then monthly.
  • Hepatic toxicity: monitor liver enzymes monthly for the first 3 months and as clinically indicated.

請告知藥師或醫師您是否懷孕或哺乳、是否患有腎臟或肝臟疾病、是否有過敏,以及您正在使用的所有其他藥物或保健品。

重要交互作用 (110)

All 110 interactions, with severity and what to do

Pro+ 會員專屬

解鎖完整頁面

建立帳號並開始 Pro+ 試用,即可開啟 Bosutinib 的完整藥品專論:劑量、懷孕與哺乳、副作用、警示及所有交互作用。

  • Dosing by age, kidney and liver function, and further dose lines
  • Renal and hepatic dose adjustments
  • Paediatric dosing
  • Dosing in older adults
  • How to give it
  • Pharmacokinetics
  • Patient counselling points
  • Food interactions
  • IV preparation and dilution

在網頁版免費試用 Pro+ 14 天,無需信用卡。

同類別的其他藥品

常見問題

What is Bosutinib used for?

Bosutinib is a medicine in the class oncology. It is used for Leukemia.

What side effects have been reported with Bosutinib?

Diarrhea, Rash, Nausea, Abdominal pain, Vomiting, Fatigue.

Can Bosutinib be taken in pregnancy or while breastfeeding?

Pregnancy: Unsafe. Can cause fetal harm; animal studies showed malformations and fetal death. No human data. Use highly effective contraception during treatment and for 2 weeks after the last dose. Breastfeeding: Unsafe. No human milk data; it passes into rat milk. Breastfeeding is not recommended during treatment and for 2 weeks after the last dose.

What does Bosutinib interact with?

MediHelp lists 110 known interactions for Bosutinib. Major: 32 · Moderate: 55 · Minor: 23. The most serious include Amiodarone, Apalutamide, Aprepitant.

在 MediHelp App 中取得完整藥品專論、劑量資訊與交互作用檢查

在 MediHelp App 中開啟完整參考資料、檢查多種藥物間的交互作用,並使用劑量工具。

依 A–Z 瀏覽 · 藥品參考

取得 App 登入